KBKatherine E. Bujold

Katherine E. Bujold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katherine E. Bujold has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Positively Charged Backbone Modifications on the Properties of Spherical Nucleic Acids

    by Katherine E. Bujold, Kacper Skakuj, John P. Cavaliere, Caroline D. Kusmierz, Chad A. Mirkin

    Spherical nucleic acids (SNAs) are nanostructures consisting of densely packed, radially oriented oligonucleotides arranged on nanoparticle cores. They are highly relevant to nanomedicine due to their unique physicochemical and biological properties, including efficient uptake across a broad range of cell types (over 50). This uptake is mediated in part by interactions between the oligonucleotide shell and scavenger receptors, making the DNA charge and sequence critical factors governing cellular internalization pathways. Recent advances in deoxynucleic guanidines (DNGs), nucleic acid analogues featuring positively charged guanidinium backbones, provide an opportunity to systematically probe how DNA charge influences SNA uptake. In this work, we report the synthesis of SNAs incorporating DNG‐DNA chimeras and evaluate how DNG incorporation alters SNA properties and cellular internalization. We find that cellular uptake increases with the number of DNG inserts, but only when these modifications are displayed on the outer surface of the SNA architecture. Furthermore, receptor blocking experiments indicate that uptake depends not only on scavenger receptor interactions but also on broader cell membrane composition. These findings demonstrate that both structural design and chemical composition can be tuned to control SNA uptake, underscoring the promise of structural nanomedicine for directing SNA‐cell interactions and rationally designing next‐generation nanotherapeutics.


  • Multivalent Peptide-DNA Conjugates Facilitate DNA Internalization in Cells Expressing Glycosaminoglycans

    by Kaitlin E. Davies, Katherine E. Bujold

    Nucleic acids (NAs) are emerging as a transformative therapeutic platform owing to their specificity, biocompatibility, and ease of modification. While cell internalization remains a central challenge, advances such as GalNAc-NA conjugates have demonstrated the transformative potential of multivalent ligand displays to achieve cell-specific delivery. We propose that this strategy can be extended to glycosaminoglycans (GAGs), which are anionic polysaccharides expressed on the surface of most cells with relevance in cell communication and the progression of various diseases. Additionally, GAGs are known to associate with cell-penetrating peptides (CPPs) that are rich in cationic residues and promote cell entry. Hence, GAGs are a promising cell–surface handle to drive CPP-mediated, GAG-dependent internalization of nucleic acids. Inspired by the success of multivalent GalNAc–nucleic acid conjugates and prior demonstrations that multivalent CPPs can probe cell–surface features, we designed a multivalent display of GAG-targeting ligands to promote DNA internalization. To achieve this, we used a known CPP, Tat, to create tetravalent CPP-DNA conjugates. These conjugates show a striking increase in GAG recognition in GAG-expressing cell lines compared to monovalent conjugates and unmodified DNA, suggesting multivalency is crucial for effective cell–surface GAG binding. However, electrostatically driven aggregation of multivalent CPP-DNA conjugates was observed for which we developed solvation methods that enable the purification, quantification, and biological evaluation of these conjugates. Flow cytometry and confocal microscopy show that the internalization of the conjugates occurs most likely via GAG-mediated endocytosis and revealed that both multivalency and the solvation method influence internalization and GAG engagement. These findings position tetravalent CPP-ssDNA conjugates as a promising platform for GAG-directed nucleic acid uptake, with broad implications for precision medicine.


  • Open Access

    Phosphoramidate-driven charge modulation enhances the cellular uptake of spherical nucleic acids

    by Joseph Maggisano, Annina Ashok, Anh Thu Do, Eric B. Liu, Katherine E. Bujold

    Amine- and guanidinium-functionalized phosphoramidate linkages provide a modular route to reprogram the charge of spherical nucleic acids, enhancing cell interactions and increasing uptake by up to an order of magnitude.

  • Top Cited Papers

    33 Unresolved Questions in Nanoscience and Nanotechnology

    by Chad A. Mirkin, Sarah Hurst Petrosko, Natalie Artzi, Koray Aydin, Austin Biaggne, C. Jeffrey Brinker, Katherine E. Bujold, Y. Charles Cao, Rachel R. Chan, Chaojian Chen, et al.

    Significant advances in science and engineering often emerge at the intersections of disciplines. Nanoscience and nanotechnology are inherently interdisciplinary, uniting researchers from chemistry, physics, biology, medicine, materials science, and engineering. This convergence has fostered novel ways of thinking and enabled the development of materials, tools, and technologies that have transformed both basic and applied research, as well as how we address critical societal challenges. In this Nano Focus, we pose and explore 33 questions whose answers could profoundly impact fields such as energy, electronics, the environment, optics, and medicine. These questions highlight the need for deeper foundational understanding, improved tools and techniques, and innovative applications─each with significant societal relevance. Together, they represent a global call-to-action for the scientific community.


  • Graft-then-Shrink Polymer Coatings for Localized Surface Plasmon Resonance Active Interfaces

    by Zengyao Qi, Katherine E. Bujold, Ryan Gavin Wylie

    Increasing the polymer content on biosensors is important to improve sensor function by altering surface properties and increasing the number of capture sites for analytes. Grafting-to methods are often employed but may be limited by insufficient polymer immobilization. Herein, we have utilized Graft-then-Shrink (GtS) to simultaneously increase polymer content on grafting-to surfaces and produce low-cost, local surface plasmon resonance (LSPR) Au biosensors. The biosensors were incorporated within microwell plates, where the translocation of materials across biological barriers can be tracked by visible light absorbance shifts as a platform for biological barrier crossing molecules. Biosensors were constructed by coating a flat Au layer on stretched polystyrene (PS) with thiol-terminated polymers that, upon heating, produced LSPR active wrinkled Au layers with ∼78% greater polymer content and lower water contact angles (WCA; ∼15°) compared to Shrink-then-Graft (StG) controls (∼55°) for PEG2MA coatings. To demonstrate translocation detection, 48-well microplates were 3D printed for GtS biosensor incorporation in the presence of a phospholipid bilayer. Using visible light to track LSPR peak shifts, cell penetrating peptides (CPPs) were screened for bilayer translocation and rate kinetics. GtS offers a simple method to increase the polymer content within coatings and an LSPR fabrication platform to track biomolecule translocation.


  • The Emergence of Oligonucleotide Building Blocks in the Multispecific Proximity-Inducing Drug Toolbox of Destruction

    by Kevin Xiao Tong Zhou, Katherine E. Bujold

    Oligonucleotides are a rapidly emerging class of therapeutics. Their most well-known examples are informational drugs that modify gene expression by binding mRNA. Despite inducing proximity between biological machinery and mRNA when applied to modulating gene expression, oligonucleotides are not typically labeled as "proximity-inducing" in literature. Yet, they have recently been explored as building blocks for multispecific proximity-inducing drugs (MPIDs). MPIDs are unique because they can direct endogenous biological machinery to destroy targeted molecules and cells, in contrast to traditional drugs that inhibit only their functions. The unique mechanism of action of MPIDs has enabled the targeting of previously "undruggable" molecular entities that cannot be effectively inhibited. However, the development of MPIDs must ensure that these molecules will selectively direct a potent, destruction-based mechanism of action toward intended targets over healthy tissues to avoid causing life-threatening toxicities. Oligonucleotides have emerged as promising building blocks for the design of MPIDs because they are sequence-controlled molecules that can be rationally designed to program multispecific binding interactions. In this Review, we examine the emergence of oligonucleotide-containing MPIDs in the proximity induction space, which has been dominated by antibody and small molecule MPID modalities. Moreover, examples of oligonucleotides developed as MPID candidates in immunotherapy and protein degradation are discussed to demonstrate the utility of oligonucleotides in expanding the scope and selectivity of the MPID toolbox. Finally, we discuss the utility of programming "AND" gates into oligonucleotide scaffolds to encode conditional responses that have the potential to be incorporated into MPIDs, which can further enhance their selectivity, thus increasing the scope of this drug category.


  • DNA Dendrons as Agents for Intracellular Delivery

    by Max E. Distler, Michelle H. Teplensky, Katherine E. Bujold, Caroline D. Kusmierz, Michael Evangelopoulos, Chad A. Mirkin

    Herein, a method for synthesizing and utilizing DNA dendrons to deliver biomolecules to living cells is reported. Inspired by high-density nucleic acid nanostructures, such as spherical nucleic acids, we hypothesized that small clusters of nucleic acids, in the form of DNA dendrons, could be conjugated to biomolecules and facilitate their cellular uptake. We show that DNA dendrons are internalized by 90% of dendritic cells after just 1 h of treatment, with a >20-fold increase in DNA delivery per cell compared with their linear counterparts. This effect is due to the interaction of the DNA dendrons with scavenger receptor-A on cell surfaces, which results in their rapid endocytosis. Moreover, when conjugated to peptides at a single attachment site, dendrons enhance the cellular delivery and activity of both the model ovalbumin 1 peptide and the therapeutically relevant thymosin alpha 1 peptide. These findings show that high-density, multivalent DNA ligands play a significant role in dictating cellular uptake of biomolecules and consequently will expand the scope of deliverable biomolecules to cells. Indeed, DNA dendrons are poised to become agents for the cellular delivery of many molecular and nanoscale materials.


  • Defining the Design Parameters for in Vivo Enzyme Delivery Through Protein Spherical Nucleic Acids

    by Caroline D. Kusmierz, Katherine E. Bujold, Cassandra E. Callmann, Chad A. Mirkin


  • Multivalent Cation-Induced Actuation of DNA-Mediated Colloidal Superlattices

    by Devleena Samanta, Aysenur Iscen, Christine R. Laramy, Sasha B. Ebrahimi, Katherine E. Bujold, George C. Schatz, Chad A. Mirkin

    Nanoparticles functionalized with DNA can assemble into ordered superlattices with defined crystal habits through programmable DNA “bonds”. Here, we examine the interactions of multivalent cations with these DNA bonds as a chemical approach for actuating colloidal superlattices. Multivalent cations alter DNA structure on the molecular scale, enabling the DNA “bond length” to be reversibly altered between 17 and 3 nm, ultimately leading to changes in the overall dimensions of the micrometer-sized superlattice. The identity, charge, and concentration of the cations each control the extent of actuation, with Ni2+ capable of inducing a remarkable >65% reversible change in crystal volume. In addition, these cations can increase “bond strength”, as evidenced by superlattice thermal stability enhancements of >60 °C relative to systems without multivalent cations. Molecular dynamics simulations provide insight into the conformational changes in DNA structure as the bond length approaches 3 nm and show that cations that screen the negative charge on the DNA backbone more effectively cause greater crystal contraction. Taken together, the use of multivalent cations represents a powerful strategy to alter superlattice structure and stability, which can impact diverse applications through dynamic control of material properties, including the optical, magnetic, and mechanical properties.


  • Mercury-Free Automated Synthesis of Guanidinium Backbone Oligonucleotides

    by Kacper Skakuj, Katherine E. Bujold, Chad A. Mirkin

    A new method for synthesizing deoxynucleic guanidine (DNG) oligonucleotides that uses iodine as a mild and inexpensive coupling reagent is reported. This method eliminates the need for the toxic mercury salts and pungent thiophenol historically used in methods aimed at preparing DNG oligonucleotides. This coupling strategy was readily translated to a standard MerMade 12 oligonucleotide synthesizer with coupling yields of 95% and has enabled the synthesis of a 20-mer DNG oligonucleotide, the longest DNG strand to date, in addition to mixed DNA–DNG sequences with 3–9 DNG inserts. Importantly, DNG oligonucleotides exhibit robust unaided cellular uptake as compared to unmodified oligonucleotides without apparent cellular toxicity. Taken together, these findings should greatly increase the accessibility of cationic backbone modifications and assist in the development of oligonucleotide-based drugs.